Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joao Pedras-Vasconcelos

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Frontiers in Bioscience (Elite Edition)|June 2, 2009
TLRs as therapeutic targets in CNS inflammation and infectionJoao Pedras-Vasconcelos, Montserrat Puig, Daniela Verthelyi
Infection and Immunity|August 23, 2005
CpG oligodeoxynucleotides increase the susceptibility of normal mice to infection by Candida albicansShuichi Ito, Joao Pedras-Vasconcelos, Dennis M Klinman
Cytokine|January 30, 2008
The IP10 (CXCL10) specific cDNA probe of the mCK-5c multiprobe RNase protection assay kit carries two nucleotide insertions that complicate the interpretation of resultsChristian Sauder, Joao Pedras-Vasconcelos, Montserrat Puig, et al.
Cellular & Molecular Immunology|August 30, 2016
CD4 and CD8 T cells mediate distinct lethal meningoencephalitis in mice challenged with Tacaribe arenavirusDerek Dc Ireland, Cecilia Tami, Joao Pedras-Vasconcelos, et al.
Annals of the New York Academy of Sciences|January 6, 2006
Design and development of thermolytic DNA oligonucleotide prodrugsAndrzej Grajkowski, Joao Pedras-Vasconcelos, Cristina Ausín, et al.
Trends in Biotechnology|June 18, 2018
Evaluating and Mitigating the Immunogenicity of Therapeutic ProteinsZuben E Sauna, Daniel Lagassé, Joao Pedras-Vasconcelos, et al.
Nucleic Acids Research|June 24, 2005
Thermolytic CpG-containing DNA oligonucleotides as potential immunotherapeutic prodrugsAndrzej Grajkowski, Joao Pedras-Vasconcelos, Vivian Wang, et al.
Journal of Innate Immunity|March 14, 2015
The Interleukin-13 Receptor-α1 Chain Is Essential for Induction of the Alternative Macrophage Activation Pathway by IL-13 but Not IL-4Faruk Sheikh, Harold Dickensheets, Joao Pedras-Vasconcelos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2006
GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitisEugene D Ponomarev, Leah P Shriver, Katarzyna Maresz, et al.
The AAPS Journal|January 8, 2026
Anti-drug Antibody Validation Testing and Reporting Harmonization AddendumHeather Myler, Johanna Mora, Joao Pedras-Vasconcelos, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Frontiers in Bioscience (Elite Edition)|June 2, 2009
TLRs as therapeutic targets in CNS inflammation and infectionJoao Pedras-Vasconcelos, Montserrat Puig, Daniela Verthelyi
Infection and Immunity|August 23, 2005
CpG oligodeoxynucleotides increase the susceptibility of normal mice to infection by Candida albicansShuichi Ito, Joao Pedras-Vasconcelos, Dennis M Klinman
Cytokine|January 30, 2008
The IP10 (CXCL10) specific cDNA probe of the mCK-5c multiprobe RNase protection assay kit carries two nucleotide insertions that complicate the interpretation of resultsChristian Sauder, Joao Pedras-Vasconcelos, Montserrat Puig, et al.
Cellular & Molecular Immunology|August 30, 2016
CD4 and CD8 T cells mediate distinct lethal meningoencephalitis in mice challenged with Tacaribe arenavirusDerek Dc Ireland, Cecilia Tami, Joao Pedras-Vasconcelos, et al.
Annals of the New York Academy of Sciences|January 6, 2006
Design and development of thermolytic DNA oligonucleotide prodrugsAndrzej Grajkowski, Joao Pedras-Vasconcelos, Cristina Ausín, et al.
Trends in Biotechnology|June 18, 2018
Evaluating and Mitigating the Immunogenicity of Therapeutic ProteinsZuben E Sauna, Daniel Lagassé, Joao Pedras-Vasconcelos, et al.
Nucleic Acids Research|June 24, 2005
Thermolytic CpG-containing DNA oligonucleotides as potential immunotherapeutic prodrugsAndrzej Grajkowski, Joao Pedras-Vasconcelos, Vivian Wang, et al.
Journal of Innate Immunity|March 14, 2015
The Interleukin-13 Receptor-α1 Chain Is Essential for Induction of the Alternative Macrophage Activation Pathway by IL-13 but Not IL-4Faruk Sheikh, Harold Dickensheets, Joao Pedras-Vasconcelos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2006
GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitisEugene D Ponomarev, Leah P Shriver, Katarzyna Maresz, et al.
The AAPS Journal|January 8, 2026
Anti-drug Antibody Validation Testing and Reporting Harmonization AddendumHeather Myler, Johanna Mora, Joao Pedras-Vasconcelos, et al.
Pageof 2